Trial intelligence / Profile preview

Comparison of Intravenous Magnesium Sulphate and Lignocaine in Attenuation of Hemodynamic Responses to Laryngoscopy and Endotracheal Intubation

NCT07793955Not yet recruiting

Start
Aug 2026
Primary completion
Sep 2026
01

Overview

Trial of magnesium sulfate in 19p13.3 microduplication syndrome (2 arms). Primary endpoints: Heart Rate, Systolic Blood Pressure and 1 more. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

magnesium sulfate
03

Conditions

19p13.3 microduplication syndrome

Beyond the preview

Go deeper on NCT07793955.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07793955.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call